Free Newsletter
E-cigarette battle lines form in federal court
Last week, we highlighted the Oregon attorney general's fight against e-cigarettes, which he considers to be a drug-delivery device being sold to consumers without proper approval from the FDA. The Wall Street Journal points out that the battle goes far beyond Oregon. It is nationwide and just beginning. The industry that markets the battery-powered tubes that turn nicotine-laced liquid into into vapor claims that it is offering products "designed to be recreational alternatives to cigarettes, not devices to wean people off nicotine." If they had to go through clinical trials, they'd be out of business or forced underground. Next week, a federal appellate court hears oral arguments on the question. Report
More stories about E-cigarettes
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: